Breast and Ovarian Cancer Risk and Risk Reduction in Jewish BRCA1/2 Mutation Carriers
β Scribed by Finkelman, B. S.; Rubinstein, W. S.; Friedman, S.; Friebel, T. M.; Dubitsky, S.; Schonberger, N. S.; Shoretz, R.; Singer, C. F.; Blum, J. L.; Tung, N.; Olopade, O. I.; Weitzel, J. N.; Lynch, H. T.; Snyder, C.; Garber, J. E.; Schildkraut, J.; Daly, M. B.; Isaacs, C.; Pichert, G.; Neuhausen, S. L.; Couch, F. J.; van't Veer, L.; Eeles, R.; Bancroft, E.; Evans, D. G.; Ganz, P. A.; Tomlinson, G. E.; Narod, S. A.; Matloff, E.; Domchek, S.; Rebbeck, T. R.
- Book ID
- 118158372
- Publisher
- American Society of Clinical Oncology
- Year
- 2012
- Tongue
- English
- Weight
- 132 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of
## Abstract Although there are several plausible biologic mechanisms whereby coffee consumption might influence the risk of breast cancer, epidemiologic evidence is limited. We assessed the association between coffee consumption and breast cancer risk among highβrisk women who carry __BRCA__ mutati